By selecting the Yes option, leaving Amgen.ie option you understand that you are leaving the corporate page of Amgen Ireland and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Europe is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Europe. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
The discovery, development and manufacturing of biologics has transformed modern medicine and patient care with entirely new types of human therapeutics, and Amgen has been at the forefront of this revolution.
In 1919, Hungarian agricultural engineer Karl Ereky foresaw a time when biology could be used for turning raw materials into useful products. He coined the term biotechnology to describe that merging of biology and technology.
Ereky’s vision has now been realized by thousands of companies and research institutions. The growing list of biotechnology products includes medicines, medical devices, and diagnostics, as well as more-resilient crops, biofuels, biomaterials, and pollution controls. While the field of biotechnology is diverse, the focus of this guide is on biotechnology medicines.
A medicine is a therapeutic substance used for treating, preventing, or curing disease. The most familiar type of medicine is a chemical compound contained in a pill, tablet, or capsule. Examples are aspirin and other pain relievers, antibiotics, antidepressants, and blood pressure drugs. This type of medicine is also known as a small molecule because the active ingredient has a chemical structure and a size that are small compared with large, complex molecules like proteins. A small molecule medicine can be made by chemists in a lab. Most medicines of this type can be taken by mouth in solid or liquid form.
A protein-based biologic or large molecule Biotechnology medicines, often referred to as biotech medicines, are large molecules that are similar or identical to the proteins and other complex substances that the body relies on to stay healthy. They are too large and too intricate to make using chemistry alone. Instead, they are made using living factories—microbes or cell lines—that are genetically modified to produce the desired molecule. A biotech medicine must be injected or infused into the body in order to protect its complex structure from being broken down by digestion if taken by mouth.
In general, any medicine made with or derived from living organisms is considered a biotech therapy, or biologic. A few of these therapies, such as insulin and certain vaccines, have been in use for many decades. Most biologics were developed after the advent of genetic engineering, which gave rise to the modern biotechnology industry in the 1970s. Amgen was one of the first companies to realise the new field’s promise and to deliver biologics to patients.
Like pharmaceuticals, biologics cannot be prescribed to patients until their use has been approved by regulators. For example, in the United States, the Food and Drug Administration evaluates new medicines and in the European Union, the European Medicines Agency manages that responsibility.
